Literature DB >> 7888360

The effect of severe psoriasis on the quality of life of 369 patients.

A Y Finlay1, E C Coles.   

Abstract

The aim of this survey was to quantify the level of handicap experienced by patients with severe psoriasis, and to assess the value that patients place on their disease using various questionnaire techniques. Dermatologists throughout the U.K. each gave a questionnaire to up to five psoriasis patients, who were either being admitted for in-patient care or were starting systemic therapy. Three hundred and sixty-nine questionnaires were completed. Of the 150 patients currently working, 59.3% had lost a mean of 26 days (SD 21.9) from work during the preceding year because of their psoriasis, and of the 180 not working 33.9% attributed not working to their psoriasis. The mean Psoriasis Disability Index (PDI) score was 38.2% (SD 23.3, n = 248), with the mean sub-scores of the 'daily activities' and 'treatment' sections being greater than those of the other three sections. Despite having severe psoriasis, the majority of patients felt that it would be worse to have diabetes, asthma or bronchitis than to have psoriasis. Forty-six, 42 and 32% considered it would be either 'better' or 'the same' to have diabetes, asthma or bronchitis, respectively. However, in those patients who also had the comparative disease, 87, 80 and 77% considered it would be 'better', or 'the same' to have the comparative disease. Forty-nine per cent of patients (n = 362) stated they would be prepared to spend 2 or 3 h each day on treatment if this might result in normal skin for the rest of the day.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7888360     DOI: 10.1111/j.1365-2133.1995.tb05019.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  62 in total

1.  A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.

Authors:  A G de Tiedra; J Mercadal; X Badía; J M Mascaró; R Lozano
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

2.  The rationale behind topical vitamin d analogs in the treatment of psoriasis: where does topical calcitriol fit in?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

Review 3.  Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability.

Authors:  William J Taylor
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

4.  Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms.

Authors:  Vera Almeida; Sofia Taveira; Maribel Teixeira; Isabel Almeida; José Rocha; Ana Teixeira
Journal:  Int J Behav Med       Date:  2017-08

Review 5.  Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments.

Authors:  Joseph G Kamel; Paul S Yamauchi
Journal:  Drugs Aging       Date:  2017-08       Impact factor: 3.923

6.  Postal questionnaire study of disability in the community associated with psoriasis.

Authors:  P O'Neill; P Kelly
Journal:  BMJ       Date:  1996-10-12

7.  Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool.

Authors:  Ivan Grozdev; Douglas Kast; Lauren Cao; Diana Carlson; Prasad Pujari; Brian Schmotzer; Denise Babineau; Elizabeth Kern; Thomas McCormick; Kevin D Cooper; Neil J Korman
Journal:  J Invest Dermatol       Date:  2011-12-29       Impact factor: 8.551

8.  Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis.

Authors:  Dónal G Fortune; Helen L Richards; Alan Corrin; Robert J Taylor; Christopher E Griffiths; Chris J Main
Journal:  J Behav Med       Date:  2003-06

9.  Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.

Authors:  Malgorzata Romanowska; Louise Reilly; Colin N A Palmer; Mattias C U Gustafsson; John Foerster
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

10.  Patients seen at the Dermatology ambulatory office in a tertiary care center in Qassim region, Saudi Arabia.

Authors:  Muhammad Shahzad; Abdullateef A Alzolibani; Ahmad A Al Robaee; Hani A Al Shobaili; Mohammad H Alsharkasy; Abdullah A Al Marshood; Abdulhakeem Al Mutiari; Abdulrahman Aldukhayel
Journal:  Int J Health Sci (Qassim)       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.